ES8307759A1 - Un procedimiento para la preparacion de pirimidinas sustitu-idas. - Google Patents

Un procedimiento para la preparacion de pirimidinas sustitu-idas.

Info

Publication number
ES8307759A1
ES8307759A1 ES506969A ES506969A ES8307759A1 ES 8307759 A1 ES8307759 A1 ES 8307759A1 ES 506969 A ES506969 A ES 506969A ES 506969 A ES506969 A ES 506969A ES 8307759 A1 ES8307759 A1 ES 8307759A1
Authority
ES
Spain
Prior art keywords
intermediates
medicine
synthesis
making
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES506969A
Other languages
English (en)
Other versions
ES506969A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES8307759A1 publication Critical patent/ES8307759A1/es
Publication of ES506969A0 publication Critical patent/ES506969A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE PIRIMIDINAS SUSTITUIDAS. SE HACE REACCIONAR UNA SAL DE GUANIDINA CON UN COMPUESTO (II) O (III) PARA DESPUES DE MANERA OPCIONAL CONVERTIR EL COMPUESTO OBTENIDO (I), X ES UN ANILLO DE SEIS MIEMBROS QUE CONTIENE TRES DOBLES ENLACES EN CUYO CASO X ES N= O CH=, DOS DOBLES ENLACES, EN CUYO CASO X ES -O- ADYACENTE A LA POSICION 5 DEL ANILLO FENILO U OTROS. TRATAMIENTO DE INFECCIONES MICROBIANAS. *FORMULA*
ES506969A 1980-11-11 1981-11-10 Un procedimiento para la preparacion de pirimidinas sustitu-idas. Granted ES506969A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036135 1980-11-11

Publications (2)

Publication Number Publication Date
ES8307759A1 true ES8307759A1 (es) 1983-07-01
ES506969A0 ES506969A0 (es) 1983-07-01

Family

ID=10517217

Family Applications (5)

Application Number Title Priority Date Filing Date
ES506969A Granted ES506969A0 (es) 1980-11-11 1981-11-10 Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES521202A Expired ES8405378A1 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521201A Granted ES521201A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521203A Granted ES521203A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521204A Expired ES8405380A1 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES521202A Expired ES8405378A1 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521201A Granted ES521201A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521203A Granted ES521203A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521204A Expired ES8405380A1 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.

Country Status (35)

Country Link
US (4) US4438267A (es)
EP (1) EP0051879B1 (es)
JP (1) JPS57114581A (es)
KR (1) KR880001736B1 (es)
AR (1) AR245447A1 (es)
AU (1) AU549449B2 (es)
CA (1) CA1186310A (es)
CS (1) CS273153B2 (es)
CY (1) CY1419A (es)
DD (1) DD201896A5 (es)
DE (1) DE3173752D1 (es)
DK (1) DK172884B1 (es)
EG (1) EG16107A (es)
ES (5) ES506969A0 (es)
FI (1) FI76333C (es)
GB (1) GB2087881B (es)
GR (1) GR81317B (es)
HK (1) HK23388A (es)
HU (1) HU188762B (es)
IE (1) IE52128B1 (es)
IL (1) IL64256A (es)
IT (1) IT1210589B (es)
MC (1) MC1418A1 (es)
MY (1) MY8600678A (es)
NO (2) NO160137C (es)
NZ (1) NZ198932A (es)
PH (2) PH22654A (es)
PL (4) PL139427B1 (es)
PT (1) PT73960B (es)
RU (1) RU1819264C (es)
SG (1) SG62686G (es)
SU (4) SU1424732A3 (es)
YU (5) YU42444B (es)
ZA (1) ZA817780B (es)
ZM (1) ZM9481A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
ZA833067B (en) * 1982-05-01 1984-12-24 Wellcome Found Antibacterial compounds
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GB8603962D0 (en) * 1986-02-18 1986-03-26 Wellcome Found Chemical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
LU86703A1 (fr) * 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
JP3309340B2 (ja) * 1995-12-04 2002-07-29 アルピダ・アーゲー ジアミノピリミジン、それらを含む医薬組成物及びそれらの抗菌剤としての用途
WO2002010156A1 (en) * 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents
DE60216281T2 (de) * 2001-06-29 2007-07-05 Ab Science Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen
WO2003002108A2 (en) * 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory diseases
US7727731B2 (en) * 2001-06-29 2010-06-01 Ab Science Potent, selective and non toxic c-kit inhibitors
JP2004537542A (ja) 2001-06-29 2004-12-16 アブ サイエンス 炎症性腸疾患（ｉｂｄ）を治療するための、チロシンキナーゼ阻害剤の使用
WO2003035050A2 (en) * 2001-09-20 2003-05-01 Ab Science Use of tyrosine kinase inhibitors for promoting hair growth
EP1427379B1 (en) * 2001-09-20 2008-08-13 AB Science Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
WO2003035049A2 (en) * 2001-09-20 2003-05-01 Ab Science Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections
JP2009513524A (ja) * 2003-07-11 2009-04-02 アルパイダ アーゲー 新規ベンゾフラン誘導体
EP1856109A1 (en) * 2005-02-18 2007-11-21 Arpida AG Novell processes for the preparation of a benzofuran
ES2601178T3 (es) * 2005-09-01 2017-02-14 F. Hoffmann-La Roche Ag Diaminopirimidinas como moduladores de P2X3 y P3X2/3
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
US20120122819A1 (en) * 2009-06-12 2012-05-17 Socpra - Sciences Et Genie S.E.C. Guanine riboswitch binding compounds and their use as antibiotics
CN102649786B (zh) * 2011-02-28 2014-08-27 郑州福源动物药业有限公司 一种2，4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2，4-(1h，3h)嘧啶的制备方法
CN103755684B (zh) * 2014-02-10 2015-09-09 青岛蔚蓝生物股份有限公司 一种巴喹普林的制备方法
US20220332714A1 (en) * 2019-06-06 2022-10-20 Beijing Tide Pharmaceutical Co., Ltd. P2x3 and/or p2x2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
WO2022217295A1 (en) * 2021-04-09 2022-10-13 The Trustees Of The University Of Pennsylvania Control of protein expression with tmp-protac compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
GB1468374A (en) 1974-03-06 1977-03-23 Wellcome Found Process for preparing a pyrimidine derivative
US4039543A (en) 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
ES521204A0 (es) 1984-06-01
ES521202A0 (es) 1984-06-01
GB2087881A (en) 1982-06-03
YU42444B (en) 1988-08-31
ZA817780B (en) 1983-06-29
NO160137B (no) 1988-12-05
ZM9481A1 (en) 1983-11-21
GR81317B (es) 1984-12-11
YU198283A (en) 1984-04-30
GB2087881B (en) 1985-05-15
US4438267A (en) 1984-03-20
IE812631L (en) 1982-05-11
DE3173752D1 (en) 1986-03-20
YU198183A (en) 1984-04-30
CS825781A2 (en) 1990-07-12
NZ198932A (en) 1985-05-31
ES8405377A1 (es) 1984-06-01
NO160137C (no) 1989-03-15
PT73960B (en) 1983-11-23
DK172884B1 (da) 1999-09-06
CY1419A (en) 1988-04-22
YU266381A (en) 1984-04-30
ES521201A0 (es) 1984-06-01
PL233754A1 (en) 1983-08-01
FI76333C (fi) 1988-10-10
DK496681A (da) 1982-05-12
IL64256A0 (en) 1982-02-28
PT73960A (en) 1981-12-01
EP0051879A3 (en) 1982-08-04
MC1418A1 (fr) 1982-10-18
KR830007628A (ko) 1983-11-04
PL239280A1 (en) 1983-08-01
IL64256A (en) 1988-01-31
US4587342A (en) 1986-05-06
PL139427B1 (en) 1987-01-31
SU1306473A3 (ru) 1987-04-23
KR880001736B1 (ko) 1988-09-10
AU7733481A (en) 1982-05-20
CA1186310A (en) 1985-04-30
HU188762B (en) 1986-05-28
SU1535379A3 (ru) 1990-01-07
PH25053A (en) 1991-01-28
US4603136A (en) 1986-07-29
JPH0474351B2 (es) 1992-11-26
ES8405379A1 (es) 1984-06-01
SU1318148A3 (ru) 1987-06-15
MY8600678A (en) 1986-12-31
ES521203A0 (es) 1984-06-01
IE52128B1 (en) 1987-06-24
NO813804L (no) 1982-05-12
JPS57114581A (en) 1982-07-16
ES8405380A1 (es) 1984-06-01
YU46697B (sh) 1994-04-05
PH22654A (en) 1988-10-28
FI76333B (fi) 1988-06-30
PL139828B1 (en) 1987-02-28
SU1424732A3 (ru) 1988-09-15
YU144288A (en) 1990-04-30
PL139827B1 (en) 1987-02-28
US4761475A (en) 1988-08-02
PL139523B1 (en) 1987-01-31
IT8149676A0 (it) 1981-11-10
EG16107A (en) 1987-10-30
EP0051879A2 (en) 1982-05-19
HK23388A (en) 1988-04-08
YU198383A (en) 1984-04-30
AU549449B2 (en) 1986-01-30
FI813546L (fi) 1982-05-12
IT1210589B (it) 1989-09-14
YU43551B (en) 1989-08-31
PL239279A1 (en) 1983-08-01
SG62686G (en) 1987-03-27
NO1994029I1 (no) 1994-12-29
PL239278A1 (en) 1983-08-01
EP0051879B1 (en) 1986-02-05
ES8405378A1 (es) 1984-06-01
RU1819264C (ru) 1993-05-30
ES506969A0 (es) 1983-07-01
CS273153B2 (en) 1991-03-12
DD201896A5 (de) 1983-08-17
AR245447A1 (es) 1994-01-31

Similar Documents

Publication Publication Date Title
ES8405377A1 (es) Un procedimiento para preparar pirimidinas sustituidas.
NZ208529A (en) 2-pyrimidinyl-1-piperazine derivatives and pharmaceutical compositions
ES472661A1 (es) Procedimiento para la preparacion de nuevos nitroimidazoles
IL64504A (en) Aminoalkoxyphenyl substituted quinazolinones and pyridopyrimidinones,their preparation and pharmaceutical compositions containing them
IL81002A0 (en) Pyrazoline derivatives,processes for their preparation and pesticidal compositions containing the same
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
PH17390A (en) Imidazolylphenyl amidines,pharmaceutical compositions containing same and use thereof
JPS5592383A (en) Novel substituted 55*22imidazolinee22yl** aminopyrimidine*its manufacture and its use as drug
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
EP0013315A3 (en) Eburnane derivatives, including intermediates, their synthesis and pharmaceutical compositions containing them
ES472284A1 (es) Procedimiento para la preparacion de 6-deoxineamina
JPS5770875A (en) Novel derivatives of 4h-1,2,4-triazole, manufacture, use as drug, composition containing them and intermediate product
IL45510A (en) 2,4-diamino-5-(4-aminobenzyl)-pyrimidine derivatives,their manufacture and antibacterial compositions containing them
IL62276A0 (en) 3,3-dimethyl-1-phenoxy-butan-2-ols,their preparation and their use as intermediates for the synthesis of fungicides
ES8302675A1 (es) "procedimiento para la preparacion de 1,2 benzisoxazoloxietilaminas".
JPS57123164A (en) Hydroxyphenyltetrahydropyridine novel derivatives and their salts, manufacture and intermediates, use as drug and composition containing same
DE3165337D1 (en) Bicyclooctane compounds, their production, compositions containing them and their pharmaceutical use
ES483165A1 (es) Un procedimiento para preparar ureas substituidas.
ES475960A1 (es) Procedimiento para la preparacion de 3-di-n-propil-acetoxi- venzodiazepin-2-onas.
IL61862A0 (en) 4,5-diaryl- -(polyhaloalkyl)-1h-imidazole-2-methanols,their preparation and pharmaceutical compositions containing them
KE3650A (en) Substituted pyrimidines,their synthesis and compositions containing them,their use in medicine and intermediates for making them
DE2960389D1 (en) 4-alkyl- and 4-allyl-thio-, sulfinyl- and sulfonyl-methyl-2-amino-6-n,n'-dimethylcarbamoyloxy pyrimidines, process for their preparation, compositions containing them and their use as insecticides
NZ187115A (en) 2,4-diamino-5-(substituted benzyl)-pyrimidines and pharmaceutical compositions
IL60169A0 (en) Guanidines,their production and pharmaceutical compositions containing them
ES483277A1 (es) Procedimiento para la obtencion de n-amino-3,4,5-tihidroxi- piperidinas